Cardiovascular adverse events associated with hydroxychloroquine and chloroquine: A comprehensive pharmacovigilance analysis of pre-COVID-19 reports.

Goldman, Adam; Bomze, David; Dankner, Rachel; Hod, Hanoch; Meirson, Tomer; Boursi, Ben; Maor, Elad

Goldman, Adam; Bomze, David; Dankner, Rachel; Hod, Hanoch; Meirson, Tomer; Boursi, Ben; Maor, Elad.

Afiliação

Goldman A; Department of Epidemiology and Preventive Medicine, School of Public Health, Sackler School of Medicine, Tel Aviv University, Israel.
Bomze D; School of Medicine, Sackler Faculty of Medicine, Tel-Aviv University, Israel.
Dankner R; Department of Epidemiology and Preventive Medicine, School of Public Health, Sackler School of Medicine, Tel Aviv University, Israel.
Hod H; School of Medicine, Sackler Faculty of Medicine, Tel-Aviv University, Israel.
Meirson T; Department of Dermatology, University Hospital of Zurich, Zurich, Switzerland.
Boursi B; Department of Epidemiology and Preventive Medicine, School of Public Health, Sackler School of Medicine, Tel Aviv University, Israel.
Maor E; Unit for Cardiovascular Epidemiology, The Gertner Institute for Epidemiology and Health Policy Research, Ramat Gan, Israel.

Br J Clin Pharmacol ; 87(3): 1432-1442, 2021 03.

Article em En | MEDLINE | ID: mdl-32964535

Assuntos

Antimaláricos/efeitos adversos; Tratamento Farmacológico da COVID-19; Doenças Cardiovasculares/induzido quimicamente; Cloroquina/efeitos adversos; Hidroxicloroquina/efeitos adversos; Farmacovigilância; Adulto; Idoso; Antimaláricos/uso terapêutico; COVID-19/complicações; Doenças Cardiovasculares/epidemiologia; Cloroquina/uso terapêutico; Bases de Dados Factuais; Overdose de Drogas; Feminino; Humanos; Hidroxicloroquina/uso terapêutico; Masculino; Pessoa de Meia-Idade; Razão de Chances; Resultado do Tratamento

Palavras-chave

COVID-19; FDA adverse events reporting system (FAERS); cardiovascular adverse events; chloroquine; hydroxychloroquine; pharmacovigilance

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doenças Cardiovasculares / Cloroquina / Farmacovigilância / Tratamento Farmacológico da COVID-19 / Hidroxicloroquina / Antimaláricos Tipo de estudo: Etiology_studies / Observational_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Br J Clin Pharmacol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Israel

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google